Hearing aids, implantable hearing aids and cochlear implants in chronic tinnitus therapy.
Summary of "Hearing aids, implantable hearing aids and cochlear implants in chronic tinnitus therapy."
Chronic tinnitus can be influenced positively by plastic cortical changes of tinnitus assignment and auditory perception. Acoustic stimulation plays an important role, either through active hearing therapy or through a hearing device. The positive effect of hearing aids regarding tinnitus loudness and severity has been shown in many studies with large numbers of patients and amounts to up to 70%. Implantable hearing systems and their effect on tinnitus have not been examined sufficiently yet; there are reports about positive as well as negative effects on tinnitus perception. There is a strong indication, however, when pathological processes in the middle ear need direct coupling of the implantable hearing aid with the stapes or the round window and there is no possibility of providing a conventional hearing aid due to high-grade combined hearing loss. Cochlear implants (CI) for profoundly deaf patients influence tinnitus loudness and severity in 34-93% of the patients; the large deviation is due to inhomogeneous parameters in the studies that are not always based on validated questionnaires. Existing tinnitus, however, influences the outcome of CI patients. There are studies and discussions about the effect of CI for unilateral deafness with tinnitus.
HNO-Klinik, Charité - Universitätsmedizin Berlin, Campus Virchow-Klinikum, Augustenburger Platz 1, 13353, Berlin, Deutschland, firstname.lastname@example.org.
This article was published in the following journal.
- PubMed Source: http://www.ncbi.nlm.nih.gov/pubmed/20811866
- DOI: http://dx.doi.org/10.1007/s00106-010-2181-z
Most patients with tinnitus also have hearing loss. Hearing aids have been well-documented to provide amelioration for both hearing and tinnitus problems. Some hearing aids have built-in noise/sound g...
Children with hearing loss are at risk of developing psychopathology, which has detrimental consequences for academic and psychosocial functioning later in life. Yet, the causes of the extensive varia...
An important goal of providing amplification to children with hearing loss is to ensure that hearing aids are adjusted to match targets of prescriptive procedures as closely as possible. The Desired S...
It has been long documented that patients may experience emotional reactions to a diagnosis of hearing impairment and recommendation of hearing aids. Because of this, patients may raise psychosocial c...
To compare the real-world verbal communication performance of children provided with cochlear implants (CIs) with their peers with hearing aids (HAs).
This study is being conducted to evaluate the benefits of in-the-ear vs. open-fit behind-the-ear hearing aids. We want to learn more about which patients prefer each type, so we can make b...
This is a 12-months’ randomized clinical trial that aims at studying the benefit of bilateral hearing aids in hearing impaired patients suffering from a slight to moderate stage Alzheime...
The proportion of elderly people is expected to increase greatly within the next couple of decades, resulting in a proportional increase in the need for hearing rehabilitation. However, st...
The middle ear implant are used for patients with mild to severe sensorineural hearing loss, who cannot benefit from conventional hearing aids because of medical reasons such as chronic ex...
The purpose of this study is to see if noise reduction programs in digital hearing aids help patients hear better than hearing aids without these programs. We also want to know if we can ...
Medical and Biotech [MESH] Definitions
Wearable sound-amplifying devices that are intended to compensate for impaired hearing. These generic devices include air-conduction hearing aids and bone-conduction hearing aids. (UMDNS, 1999)
Multi-channel hearing devices typically used for patients who have tumors on the COCHLEAR NERVE and are unable to benefit from COCHLEAR IMPLANTS after tumor surgery that severs the cochlear nerve. The device electrically stimulates the nerves of cochlea nucleus in the BRAIN STEM rather than the inner ear as in cochlear implants.
Surgical insertion of an electronic hearing device (COCHLEAR IMPLANTS) with electrodes to the COCHLEAR NERVE in the inner ear to create sound sensation in patients with residual nerve fibers.
Hearing loss due to disease of the AUDITORY PATHWAYS (in the CENTRAL NERVOUS SYSTEM) which originate in the COCHLEAR NUCLEI of the PONS and then ascend bilaterally to the MIDBRAIN, the THALAMUS, and then the AUDITORY CORTEX in the TEMPORAL LOBE. Bilateral lesions of the auditory pathways are usually required to cause central hearing loss. Cortical deafness refers to loss of hearing due to bilateral auditory cortex lesions. Unilateral BRAIN STEM lesions involving the cochlear nuclei may result in unilateral hearing loss.
The cochlear part of the 8th cranial nerve (VESTIBULOCOCHLEAR NERVE). The cochlear nerve fibers originate from neurons of the SPIRAL GANGLION and project peripherally to cochlear hair cells and centrally to the cochlear nuclei (COCHLEAR NUCLEUS) of the BRAIN STEM. They mediate the sense of hearing.